Maturitas
Volume 55 , Pages S83-S91 , 1 November 2006

Efficacy and tolerability of the Black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: A double-blind, placebo- and conjugated estrogens-controlled study

  • Wolfgang Wuttke

      Affiliations

    • Division of Clinical and Experimental Endocrinology, Department of Obstetrics and Gynaecology, Georg-August University, Göttingen, Germany
    • Corresponding Author InformationCorresponding author at: Abt. Klin. und Exp. Endokrinologie, Universitäts-Frauenklinik Göttingen, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany. Tel.: +49 551 396714; fax: +49 551 396518.
    • ,
  • Karel Rauš

      Affiliations

    • Department of Obstetrics and Gynecology, Charles University Teaching Hospital, Prague, Czech Republic
    • ,
  • Christoph Gorkow

      Affiliations

    • Bionorica AG, Neumarkt, Germany

References 

  1. Willhite LA, O’Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy. 2001;21:464–480
  2. Hextall A. Oestrogens and lower urinary tract function. Maturitas. 2000;36(2):83–92
  3. Bjarnason NH, Hassager C, Christiansen C. Postmenopausal bone remodelling and hormone replacement. Climacteric. 1998;1:72–79
  4. Greendale GA, Reboussin BA, et al. Symptom relief and side effects of postmenopausal hormone results from the postmenopausal estrogen/progestin interventions trial. Obstet Gynecol. 1998;92:982–988
  5. O’Connell D, Robertson J, Henry D, Gillespie W. A systemic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects. Climacteric. 1998;1:112–123
  6. Samsioe G. Urogenital aging—a hidden problem. Am J Obstet Gynecol. 1998;178(5):245–249
  7. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002;53(3):605–619
  8. Herrington DM, Potvin Klein K. Cardiovascular trials of estrogen replacement therapy. Ann NY Acad Sci. 2001;949:153–162
  9. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133(12):933–941
  10. Hulley S, Grady D, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmeno-pausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA. 1998;280:605–613
  11. Rossouw JE, Anderson GL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321–333
  12. Liehr JG. Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update. 2001;7:273–281
  13. Cauley JA, Norton L, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple out-comes of raloxifene evaluation. Breast Cancer Res Treat. 2001;65:125–134
  14. Southcott BM. Carcinoma of the endometrium. Drugs. 2001;61(10):1395–1405
  15. Feeley KM, Wells M. Hormone replacement therapy and the endometrium. J Clin Pathol. 2001;54(6):435–440
  16. Borrelli F, Ernst E. Cimicifuga racemosa: a systematic review of its clinical efficacy. Eur J Clin Pharmacol. 2002;58(4):235–241
  17. Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm. 1999;56(14):1400–1402
  18. Saller R. Cimicifuga: Die Wirksamkeit ist dosisabhängig [Cimicifuga: efficacy response to the dose] Komitee Forschung Naturmedizin e.V. (KFN); 2005.
  19. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol. 2005;105(5 Pt 1):1074–1083
  20. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch , Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas. 2005;51(4):397–404
  21. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003;44(Suppl 1):67–77
  22. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhi-zoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Women Health Gend Based Med. 2002;11:163–174
  23. Lehmann-Willenbrock E, Riedel HH. Klinische und endokrinologische Untersuchungen zur Therapie ovarieller Ausfallserscheinungen nach Hysterektomie unter Belassung der Adnexe. Zentralbl Gynakol. 1988;110:611–618
  24. Stoll W. Phytotherapeutikum beeinflusst atrophisches Vaginalepithel: Doppelblindversuch Cimicifuga vs Östrogenpräparat [Phytopharmacon influences atrophic vaginal epithelium: double-blind study—Cimicifuga vs. estrogenic substances]. Therapeuticum. 1987;1:23–31
  25. Warnecke G. Beeinflussung klimakterischer Beschwerden durch ein Phytotherapeutikum. Erfolgreiche Therapie mit Cimicifuga-Monoextrakt. Med Welt. 1985;36:871–874
  26. Anthony M, Williams JK, Dunn BK. What would be the properties of an ideal SERM?. Ann NY Acad Sci. 2001;949:261–278
  27. Seidlova-Wuttke D, Hesse O, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol. 2003;149(4):351–362
  28. Düker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med. 1991;57:420–424
  29. Seidlova-Wuttke D, Hesse O, Jarry H, Becker T, Christoffel V, Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas. 2003;44(Suppl 1):39–50
  30. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas. 1996;25:149–153
  31. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas. 2003;44(Suppl 1):31–38
  32. CPMP/ICH/135/95. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Note for guidance on good clinical practice. Committee for Propietary Medicinal Product (CPMP), London; 1997.
  33. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Last amended by the 48th World Medical Assembly, Sommerset West, Republic of South Africa; 1996.
  34. Dallal GE. Design—power analysis and expected mean squares. A supplementary module for SYSTAT and SYSGRAPH. Evanston, IL: Systat Inc.; 1988;
  35. Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG. Evaluation der klimakterischen Beschwerden (Menopause Rating Scale [MRS]). Zentralbl Gynakol. 1994;116:16–23
  36. Wuttke W, Gorkow C, Seidlova-Wuttke D. Effects of Black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa and on various blood parameters in postmenopausal women: a double-blind, placebo- and conjugated estrogens-controlled study. Menopause. 2006;13(2):185–196
  37. Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. JAMA. 1959;171:1627–1637
  38. Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The menopause rating scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric. 2000;3(1):50–58
  39. CHMP/EWP/021/97 Ref.1. The European Agency for the evaluation of medicinal products for human use. Committee for medicinal products for human use (CHMP). Guideline on clinical investigation of medicinal products for the treatment of hormone replacement therapy, Draft, London; 2005.

PII: S0378-5122(06)00242-8

doi: 10.1016/j.maturitas.2006.06.020

Maturitas
Volume 55 , Pages S83-S91 , 1 November 2006

Article Tools

* Image Usage & Resolution